SETDB1 and neoplasm: In cancer, dysregulation of H3K9me3 via aberrant SETDB1 expression can silence tumour suppressor genes such as APOE, p53 and HoxA, and promote a more aggressive tumour phenotype in melanoma, ovarian, lung, liver and breast cancers [72].